| Dr Melissa Mcguinn King, MD | |
|
307 Boatner Rd Ste 114, Eglin Afb, FL 32542-1302 | |
| (850) 883-8100 | |
| (850) 883-8517 |
| Full Name | Dr Melissa Mcguinn King |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 21 Years |
| Location | 307 Boatner Rd Ste 114, Eglin Afb, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336340637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 0101238053 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Walton Beach Medical Center | Fort walton beach, FL | Hospital |
| Twin Cities Hospital | Niceville, FL | Hospital |
| Sacred Heart Hospital On The Emerald Coast | Miramar beach, FL | Hospital |
| North Okaloosa Medical Center | Crestview, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emerald Coast Oncology And Hematology Assoc., P.a. | 2163557760 | 5 |
News Archive
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.
Long-term use of commonly prescribed heartburn and ulcer medications is linked to a higher risk of vitamin B12 deficiency, according to a new study published online in the Journal of the American Medical Association.
A gene that helps to control inflammation increases the risk of obesity and could be turned off in mice to stop weight gain, a study from The University of Queensland has found.
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
› Verified 2 days ago
| Entity Name | Emerald Coast Oncology And Hematology Assoc., P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861421919 PECOS PAC ID: 2163557760 Enrollment ID: O20100322000627 |
News Archive
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.
Long-term use of commonly prescribed heartburn and ulcer medications is linked to a higher risk of vitamin B12 deficiency, according to a new study published online in the Journal of the American Medical Association.
A gene that helps to control inflammation increases the risk of obesity and could be turned off in mice to stop weight gain, a study from The University of Queensland has found.
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Mcguinn King, MD 307 Boatner Rd Ste 114, Eglin Afb, FL 32542-1302 Ph: (850) 883-8100 | Dr Melissa Mcguinn King, MD 307 Boatner Rd Ste 114, Eglin Afb, FL 32542-1302 Ph: (850) 883-8100 |
News Archive
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.
Long-term use of commonly prescribed heartburn and ulcer medications is linked to a higher risk of vitamin B12 deficiency, according to a new study published online in the Journal of the American Medical Association.
A gene that helps to control inflammation increases the risk of obesity and could be turned off in mice to stop weight gain, a study from The University of Queensland has found.
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
› Verified 2 days ago
Anjeli Kristen Nayar Pope, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-9906 | |
Dr. Jaclyn Harris, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8600 | |
Ronald Rasor, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd, Suite 114 Sgomi, Eglin Afb, FL 32542 Phone: 850-883-8435 Fax: 850-883-8517 | |
Dr. Peerach Phermsangngam Ewings, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8600 | |
Dr. Benjamin Steven Goins, DO Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8358 | |
Dr. Mitchell Bowman, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8600 | |
Blake Richard Shaffer, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8600 |